Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
US9737535B2 · kind B2 · utility
5Cited by
21References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2015 |
| Grant date | Aug 22, 2017 |
| Priority date | — |
| Expiry date | Aug 17, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount a second active agent to a patient having a cancer, wherein the TOR kinase inhibitor is a compound of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.